The Polysaccharides of a Human Carcinoma by Cudkowicz, G.
758
THE POLYSACCHARIDES OF A HUMAN CARCINOMA
G. CUDKOWICZ*
From the Institute of Biochemistry, University of Uppsala, Uppsala, Sweden
Received for publication October 2, 1956
THE composition ofmesenchymal tumour polysaccharides has been repeatedly
investigated: Kabat (1939) obtained from two fowl sarcomas a substance very
similar to the hyaluronic acid of human umbilical cords and Pirie (1942) isolated
hyaluronic acid from Rous and Fujinami myxosarcomas. Warren and co-workers
(1949) reported that the hyaluronic acid extractable from fresh Rous chicken
sarcomas had a lower viscosity than the one usually extracted from umbilical cord.
Previous data of Sylven (1945, 1949) and of successive extraction and fractiona-
tion experiments (Harris, Malmgren and Sylven, 1954) suggest the simultaneous
presence in the ground substance of mesenchymal tumours of an ester sulphate
polysaccharide, which is believed to be a heparin-like one.
In this paper a similar detailed investigation on the polysaccharides extractable
from a human carcinoma is reported. Present data will be compared with those
for the polysaccharides of Rous sarcoma No. 1 and of human umbilical cords
prepared by the same extraction and purification methods.
MATERIAL AND METHODS
The tumourtissue, anundifferentiated carcinomaoriginatingfrom thepancreas,
was obtained from a male patient, aged 66, who died in January 1949. It was
supplied by Dr. D. A. G. Galton and Dr. R. J. C. Harris, Chester Beatty Research
Institute, London.
The extraction and the purification of polysaccharides from the acetone-
defatted and dried material was carried out according to Harris, Malmgren and
Sylven (1954). The extraction schemes are shown overleaf.
The corresponding preparations from umbilical cords were denoted (U-I)
to (U-V).
Each fraction was analysed for nitrogen (Kjeldahl), sulphur (Paulsson, 1953),
phosphorus (Lowry and Lopez, 1946) and hexosamine (Blix, 1948) after hydrolysis
for 24 hours in 4 M HCI at 100°C. The hexosamine was identified by ion exhcange
chromatography combined with automatic recording of electrolytic conductivity
according to Drake and Gardell (1952).
Determinations of the eletrophoretic mobility and sedimentation coefficient
were carried out at a concentration of 05 per cent in phosphate buffers of pH-
7-6 and 6-8 at an ionic strength of 0-1.
RESULTS
The analytical and physico-chemical data are given in Table I.
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TABLE I.-Analytical and Physico-chemical Data
Umbilical cord
polysaccharides
(U-I) (U-II) (U-V)
Carcinoma
polysaccharides
(C-I) (C-II) ((>V) Nitrogen in per cent . . 3-80 324 6-20 . 2-95 3*12 4-20
Sulphur in per cent . . 100 001 103 . 057 0 01 0 47
Phosphorus in per cent . . . 007 - . 0-10 -
Hexosamine in per cent 30*9 44*4t 250 . 29*8 31*8 29*1
Hexosamine in fGlucosamine . 81 100 84 .100 100 100
relative amount Galactosamine . 19 - 16
Electrophoretic mobility x 105 cm.2/ 10-0 - 107 . 102 - 10*4
volt sec. at + 0Q5° C.
Sedimentation coefficient Svedberg - 192 2-35 . - 1.01 1P38
units
Optical rotation [c]20D - 35° to -40°* - _ 530
Rous
sarcoma No. 1
polysac-
charides*
(S-I) (S-II)
. 3-11 3 29
0 80 0*01
0*05 -
. 43 0 42'2
-100
9.9 9.9
. 1-08 0-98
-440
* According to Harris, Malmgren and Sylven (1954).
t Theoretical value; the values obtained are usually about 10 per cent (absolute) lower.
The total yield of polysaccharide material from the human carcinoma was
about 2-5 per cent fof the fat-free dry weight. Scheme 1 and Table I show that
about 90 per cent of this is hyaluronic acid. The chemical composition and the
electrophoretic mobility are quite similar to those of purified hyaluronic acid
from human umbilical cords and from Rous fowl sarcoma. Infra-red spectroscopy
(kindly performed by Dr. S. F. D. Orr) has also shown that the spectrum of
preparation (C-II) is very similar to that of pure hyaluronate prepared from
human umbilical cord and from Rous sarcoma (Orr, Harris and Sylven, 1952).
The two spectra were identical in the region 680-980 cm.-', indicating that
the two samples have the same molecular skeleton (Orr, 1954). The sedimentation
coefficient of the carcinoma polysaccharide is similar to that of sarcoma polysac-
charide; however, it is lower than that of the corresponding umbilical cord
preparation (U-II).
The sulphur-bearing constituent present in preparation (C-I) is completely
removed by the Azure A precipitation method of Sylven and Malmgren (1952)
and is accordingly expected to be an ester sulphate polysaccharide. No galacto-
samine could be detected in (C-I) nor in (S-I) and the presence of chondroitin-
sulphuric acid in measureable amounts, namely more than 2 per cent of total
polysaccharide, is therefore excluded. The sulphur-containing substance in
(C-I) is probably heparin or a sulphate ester of hyaluronic acid. However, none
ofthe preparations labelled (C-I), (C-II), (U-I) and (U-Il) showed antithrombic
activity. This suggests that heparin is absent or that the heparin activity has
been destroyed during the preparation.
The extraction ofthe carcinoma with detergents (Snellman) yielded an impure
hyaluronic acid (C-V), and neither of the fractions (C-III), (C-IV) or (C-V)
had antithrombic activity. The first two fractions were obtained in amounts
too small to permit chemical analysis. The sedimentation coefficient of (U-V)
is higher than that of (C-V) and the latter contains only glucosamine whereas
theumbilical cordpreparation (U-V) containsbothglucosamineandgalactosamine.
Extraction of the carcinoma according to Wilander (1938) yielded a sulphur-
containing polysaccharide moiety (S content 1-04 per cent) that did not, however,
exhibit heparin activity. Extraction ofumbilical cords gave a similar material.
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DISCUSSION
This human undifferentiated carcinoma contained about 2-5 per cent poly-
saccharide material (fat-free dryweight). About 90percentofthiswasundoubtedly
hyaluronate for its chemical properties which were identical with those of hyalu-
ronic acid from human umbilical cord. The carcinoma hyaluronate, however,
was oflower particle size than the umbilical. All these findings are in agreement
with the observations of Warren and his co-workers (1949) and also of those of
Harris, Malmgren and Sylven (1954) for the hyaluronate of Rous fowl sarcoma,
Scheme 1: Extraction and Purification Scheme of Crude Defatted Tumour
Material ((C) 5 g.) for Polysaccharides
Extraction with 2 per cent phenol; three times
Centrifugation
SEDILENT SUPERJATANT
discarded
1. NaCl added up to 1 per cent.
2. Precipitation with 3 vol. ethanol.
3. Precipitate dissolved in water and
successively shaken with chloro-
form at pH = 8, 6 and 4. Dena-
tured proteins removed by centri-
fugation.
4. Digestion with ribonuclease at pH
8 2-3 days at 370 C.
5. Dialysis against distilled water.
Addition of "Azure A" (dimethyl- 6. The bulk of dialysis residue lyo-
thionine) to part of dialysis residue. philized (C-I).
The metachromatic precipitate re- Yield 140 mg.
moved in Spinco Model L centrifuge
(rotor 440; 60 min. at 30,000 r.p.m.
Excess ofdye removed byion-exchange
resin (Dowex 50).
The filtrate lyophilized (C-II).
Yield 90 per cent of total polysac-
charide material.
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indicating that mesenchymal and epithelial tumour hyaluronates are quite
similar.
The sulphur-containing polysaccharide which constituted about 10 per cent
of the total polysaccharide has not been identified. It contains only glucosamine
and cannot therefore be chondroitin-sulphuric acid. On the other hand no anti-
thrombic activity was observed, indicating that heparin or heparin-like substances
such as the sulphate esters of hyaluronic acid, were not present in an active
As preliminary data indicated the presence of a sulphur containing polysac-
charide, part of the crude tumour tissue (C) was extracted for heparin according
to Wilander (1938), and part by a milder method used by 0. Snellman (personal
communication). The following scheme was adopted:
Scheme 2: Extraction Scheme of Crude Defatted Tumour Material ((C) 3 g.)
0- for Heparin and other Polysaccharides
Extraction in 0-5 per cent Duponol (detergent).
50 per cent saturation with (NH4)2SO4.
Centrifugation.
Supernatant dialyzed against water.
Ba-acetate added to 3 her cent (w/v).
-I
PRECIPITATE
Dissolved in Na-salt ofethylene-
diamine tetra-acetic acid.
Dyalized and lyophilized.
Yield 4 mg. (C-Il1).
SUPERNATANT
Ethanol added to 20 per cent by vol.
PRECIPITATE
Dissolved in Na-salt of
ethylenediamine tetra-
acetic acid.
Dialyzed and lyophilized.
Yield 7 mg. (C-IV).
SUPERNATANT
Ethanol added to 50 per cent
by vol.
PRECIPITATE
Dissolved in Na-slt ofethylene-
diamine tetra-acetic acid.
Dialyzed and lyophilized.
Yield 108 mg. (G-V).
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state. In umbilical cord this sulphur-containing polysaccharide (perhaps a
mucoitin-sulphuric acid ?) is not present in appreciable amounts since the sulphur
contents of (U-I) and (U-V) correspond almost exactly with the galactosamine
present. The corresponding sulphur bearing polysaccharide of Rous sarcoma also
contains only glucosamine, however the sulphur content is higher and an
antithrombic activity is detectable (Harris, Malmgren and Sylven, 1954).
SUMMARY
Extraction experiments show that a human undifferentiated carcinoma,
originating from the pancreas, is rich in hyaluronate which has been identified
by chemical, spectroscopic and physico-chemical methods. The particle size of
this tumour hyaluronate is smaJler than that of normal umbilical hyaluronate,
but ofthe same order ofRous fowl sarcoma hyaluronate.
In addition to the hyaluronic acid some unidentified sulphur-bearing poly-
saccharide was found, which contained glucosamine. The material is provisionally
assumed to be chemically related to heparin-like substances, such as sulphate
esters of hyaluronic acid, but exhibits no antithrombic activity.
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